Repeated unpredictable stress and social isolation induce chronic HPA axis dysfunction and persistent abnormal fear...

Area of Science:

• Neuroscience
• Endocrinology
• Pharmacology

Background:

• Current treatments for post-traumatic stress disorder (PTSD) offer limited efficacy and primarily address symptoms, not the underlying causes.
• There is a critical need for effective, etiology-based treatments for PTSD, necessitating a deeper understanding of stress's neurobiological impacts.
• Animal models are essential for investigating the complex neurobiological and behavioral outcomes of chronic stress.

Purpose of the Study:

• To investigate the effects of chronic unpredictable stress (CUS) on hypothalamic-pituitary-adrenal (HPA) axis function and fear memory in a mouse model.
• To explore the potential of targeting adrenal receptors for treating stress-related disorders.
• To assess the efficacy of peripheral glucocorticoid receptor agonist supplementation in mitigating stress-induced behavioral deficits.

Main Methods:

• Mice were subjected to 21 days of repeated unpredictable stress (RUS), including predator stress, restraint, and foot shock, followed by social isolation.
• Neuroendocrine, biochemical, and behavioral measures were used to assess HPA axis function and fear memory recall one month post-stress.
• The study examined alterations in adrenal MC2 receptor reactivity, hypothalamic corticotropin-releasing hormone (CRH), and phosphorylated glucocorticoid receptors.

Main Results:

• Mice exposed to the RUS paradigm exhibited exaggerated fear memory recall and blunted HPA axis functionality.
• Attenuated stress response was linked to altered adrenal MC2 receptor reactivity, with no significant changes in pituitary negative feedback.
• Chronic low-dose dexamethasone supplementation post-RUS partially restored stress-related behavioral deficits, suggesting a link between HPA axis function and behavior.

Conclusions:

• Chronic stress significantly disrupts HPA axis function and exacerbates fear memory in mice.
• Adrenal receptor reactivity appears to be a key factor in HPA axis dysfunction following chronic stress.
• Targeting adrenal receptors offers a promising therapeutic avenue for stress and fear-related disorders like PTSD.